Samuel R. Nussbaum's Insider Trades & SAST Disclosures

Samuel R. Nussbaum's most recent trade in Biora Therapeutics Inc was a trade of 51,724 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2021.

Share

Note

This is a custom search result for pattern Samuel R. Nussbaum.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Biora Therapeutics Inc Board Meeting	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2021	51,724	51,724	-		-	Stock Option (Right to Buy)
Biora Therapeutics Inc Board Meeting	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2021	29,183	47,518	-		0	Common Stock
Motus GI Holdings Inc Board Meeting	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Feb 2021	30,000	77,464 (0%)	0%		0	Common Stock, par value $0.0001 per share
Motus GI Holdings Inc Board Meeting	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Feb 2021	30,000	30,000	-		-	Stock Option (right to buy)
Motus GI Holdings Inc Board Meeting	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Feb 2021	20,225	97,689 (0%)	0%		0	Common Stock, par value $0.0001 per share
Motus GI Holdings Inc Board Meeting	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2021	8,334	47,464 (0%)	0%		0	Common Stock, par value $0.0001 per share
Coherus Biosciences Inc	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	20,000	20,000	-		-	Stock Option (Right to Buy)
Motus GI Holdings Inc Board Meeting	Samuel R. Nussbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Oct 2020	9,430	39,130 (0%)	0%		0	Common Stock, par value $0.0001 per share

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades